Toxic Dose of Paracetamol
In acute single ingestions, paracetamol becomes potentially hepatotoxic at doses of ≥10 g or ≥200 mg/kg (whichever is less) in adults and children ≥6 years, and ≥200 mg/kg in children <6 years. 1, 2, 3
Acute Single Ingestion Thresholds
The toxic dose varies by age and clinical context:
Adults and Children ≥6 Years
- Emergency department referral required: ≥10 g or ≥200 mg/kg (whichever is less) 2, 3
- Hepatotoxicity unlikely: <125 mg/kg 4
- Maximum safe daily therapeutic dose: 4000 mg (4 g) 5
Children <6 Years
- Emergency department referral required: ≥200 mg/kg 2, 3
- Home observation acceptable: <200 mg/kg 2
- Children generally tolerate higher doses per kilogram without liver damage compared to adults 4
Repeated Supratherapeutic Ingestion (RSTI)
RSTI represents a distinct and potentially more dangerous pattern, with worse prognosis than acute overdose 1. Emergency department referral is warranted if:
Children <6 Years
- ≥200 mg/kg over single 24-hour period, OR
- ≥150 mg/kg per 24-hour period for preceding 48 hours, OR
- ≥100 mg/kg per 24-hour period for ≥72 hours 2
Adults and Children ≥6 Years
- ≥10 g or ≥200 mg/kg (whichever is less) over single 24-hour period, OR
- ≥6 g or ≥150 mg/kg (whichever is less) per 24-hour period for preceding 48 hours or longer 1, 2, 3
High-Risk Patients
For patients with increased susceptibility (chronic alcohol use, isoniazid therapy, prolonged fasting, enzyme-inducing drugs), the threshold should be lowered to:
Critical Clinical Considerations
Massive Overdose
Ingestions of ≥30 g or ≥500 mg/kg require increased acetylcysteine dosing due to higher risk of severe hepatotoxicity 7. Paracetamol concentrations more than double the nomogram line indicate massive overdose requiring modified treatment 7.
Modified-Release Formulations
All potentially toxic modified-release ingestions (≥10 g or ≥200 mg/kg, whichever is less) require full acetylcysteine treatment 7. These formulations demonstrate:
- Persistently elevated paracetamol concentrations
- Double peaks (sometimes >24 hours post-ingestion)
- Higher hepatotoxicity rates (18%) despite early treatment
- 10% of patients cross the nomogram line after initially non-toxic levels 8
Timing and Risk Stratification
The Rumack-Matthew nomogram is used for risk stratification only when:
- Single acute ingestion with known time
- Immediate-release formulation
- Presentation within 24 hours
- Serum level drawn 4-24 hours post-ingestion 1
Common pitfall: The nomogram cannot be used for repeated supratherapeutic ingestions, unknown ingestion times, delayed presentations >24 hours, or extended-release preparations 1.
Hepatotoxicity Outcomes
Without treatment, severe liver damage (AST >1000 IU/L) occurs in at least 50% of patients with levels above the treatment line 4. However, mortality from paracetamol overdose is approximately 0.4% with appropriate treatment 4. Treatment efficacy is time-dependent:
- NAC within 8 hours: minimal hepatotoxicity (2.9%) 1
- NAC 8-10 hours: 6.1% severe hepatotoxicity 1
- NAC >10 hours: 26.4% severe hepatotoxicity 1
FDA Warning Thresholds
The FDA label explicitly warns that severe liver damage may occur if an adult takes >6 doses in 24 hours or >4000 mg total daily 5. This represents the maximum therapeutic threshold, not the toxic threshold.
Key distinction: Therapeutic misadventure (exceeding 4 g/day) differs from acute toxic ingestion (≥10 g or ≥200 mg/kg). Both require evaluation but follow different risk assessment pathways 1.